• HBsAg Hijacks TBK1: Interferon Suppression and Autophagy in

  2026-07-04

  This study reveals that hepatitis B surface antigen (HBsAg) manipulates TANK-binding kinase 1 (TBK1) to inhibit type I interferon production and induce early autophagy, promoting persistent HBV infection. The findings offer a mechanistic bridge between viral immune evasion and autophagy regulation, with implications for targeted pathway research.

• AAPH (2,2'-Azobis(2-methylpropionamidine) Dihydrochloride) f

  2026-07-03

  AAPH enables controlled, reproducible induction of oxidative stress and lipid peroxidation in cell and erythrocyte systems, making it a gold standard for evaluating antioxidant efficacy and membrane vulnerability. Its stability and water solubility allow precise modeling of redox phenomena, supporting advanced research from cancer biology to food science.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-07-03

  This study reveals significant sex-dependent differences in the development of angiotensin II-induced hypertension in conscious mice. By integrating telemetry and pharmacological ganglionic blockade, the researchers demonstrate that males experience a greater hypertensive response than females, highlighting distinct roles for sex hormones and sympathetic nerve activity in blood pressure regulation. These findings inform the design of preclinical models that account for sex as a biological variable in cardiovascular research.

• Synthetic mRNA-Driven Differentiation of hiPSCs into Oligode

  2026-07-02

  This study demonstrates a rapid, virus-free method for differentiating human-induced pluripotent stem cells (hiPSCs) into functional oligodendrocytes using a synthetic modified mRNA (smRNA) encoding a phospho-mutant OLIG2 transcription factor. The approach addresses safety and efficiency challenges in generating oligodendrocyte progenitors, offering new avenues for regenerative therapies targeting demyelinating diseases.

• Cy5-UTP (Cyanine 5-UTP): Precision RNA Labeling for Viabilit

  2026-07-02

  This scenario-driven article addresses core workflow and data reliability challenges in cell viability and RNA detection assays, demonstrating how Cy5-UTP (Cyanine 5-UTP, SKU B8333) delivers reproducible, high-sensitivity results. Evidence-backed recommendations guide biomedical researchers in optimizing in vitro transcription RNA labeling and downstream applications.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Workflow & Troubles

  2026-07-01

  The FITC Goat Anti-Mouse IgG (H+L) Antibody unlocks heightened sensitivity and reproducibility for immunofluorescence and flow cytometry, thanks to its affinity-purified, fluorescein-conjugated design. Explore advanced protocol enhancements, application-driven troubleshooting, and how this reagent bridges cutting-edge antiviral and immunomodulation research.

• Sisomicin: Applied Workflows for Antibacterial Research Succ

  2026-07-01

  Sisomicin, a potent aminoglycoside antibiotic, drives high-precision bacterial inhibition across Gram-negative and Gram-positive research models. This guide translates pivotal in vitro findings into actionable protocols, workflow enhancements, and troubleshooting strategies for advanced infection biology.

• NAT10-Driven N4-Acetylcytidine Modulates Mouse Oocyte Matura

  2026-06-30

  The reference study reveals that NAT10-mediated N4-acetylcytidine (ac4C) modification is a critical regulator of post-transcriptional gene expression during mouse oocyte maturation in vitro. By dissecting NAT10's role and identifying a potential ac4C-binding protein, this work advances understanding of epitranscriptomic control mechanisms relevant to reproductive biology.

• Actinomycin D in Experimental Workflows: Protocols & Innovat

  2026-06-30

  Actinomycin D (ActD) is the cornerstone for transcriptional inhibition and mRNA stability studies, enabling precise apoptosis and transcriptional stress workflows. This article delivers actionable protocol enhancements, troubleshooting strategies, and bridges recent vascular calcification research to practical assay design using APExBIO's Actinomycin D.

• Gemcitabine HCl in Pancreatic Cancer Models: Mechanistic Dep

  2026-06-29

  Explore the profound impact of Gemcitabine HCl on DNA replication inhibition and apoptosis induction in pancreatic cancer, with a unique focus on integrating advanced multianimal MRI for robust preclinical assay design. This article offers deeper insight into molecular mechanisms and practical imaging strategies, setting it apart from existing content.

• Locally Produced DENV-1 Nucleic Acid Diagnostic for Endemic

  2026-06-29

  This study reports the development of a reverse transcriptase-LAMP (RT-LAMP) assay for Dengue virus serotype 1 (DENV-1), specifically optimized for local production and use in low-resource, endemic regions. The paper demonstrates how recombinant enzyme engineering and workflow simplification can overcome supply chain limitations, potentially expanding access to molecular diagnostics in settings with limited infrastructure.

• NO-Driven S-Nitrosylation Regulates Aluminum Resistance in A

  2026-06-28

  This study uncovers how nitric oxide (NO)-mediated S-nitrosylation differentially regulates the stability of STOP1 and STAR1, two key proteins orchestrating aluminum resistance in Arabidopsis. The findings provide a mechanistic framework for how plants balance external and internal detoxification, with broad implications for crop adaptation to acidic soils.

• A40926: Dalbavancin Precursor for Advanced Antibacterial Ass

  2026-06-27

  A40926 stands out as a rigorously characterized dalbavancin precursor, enabling high-impact research on Gram-positive pathogens and Neisseria gonorrhoeae. Its robust activity, well-defined mechanism, and optimized workflows make it indispensable for antibiotic development, resistance studies, and cell wall synthesis research.

• EPI-001: Androgen Receptor N-Terminal Domain Inhibitor in Ca

  2026-06-26

  EPI-001 enables precise targeting of both full-length and splice-variant androgen receptors, unlocking new experimental strategies for castration-resistant prostate cancer and aggressive triple-negative breast cancer models. Its unique mechanism and robust preclinical data position EPI-001 as an indispensable tool for dissecting AR-driven transcriptional and metastatic pathways.

• Rapamycin (Sirolimus): Applied mTOR Inhibition Workflows

  2026-06-26

  Rapamycin (Sirolimus) delivers precise, nanomolar mTOR inhibition for advanced cell signaling and mitochondrial disease research. This article unpacks actionable protocols, troubleshooting insights, and experimental enhancements that set APExBIO's Rapamycin apart as the gold standard for cell biology, cancer, and immunology investigations.

444 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page